MILANO-PILOT: WILL INFUSING HDL MIMETICS CONTAINING APOA-IMILANO CONTINUE TO REGRESS CORONARY ATHEROSCLEROSIS IN THE MODERN ERA OF INTENSIVE STATIN THERAPY?